News

Pfizer, BioNTech and rna

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal. Last year, the High Cou
Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna’s patents at London’s Court of Appeal.
Pfizer and BioNTech lose UK court appeal over Covid-19 jab
Pfizer says it will appeal the Aug 1 ruling to Britain’s Supreme Court. Read more at straitstimes.com. Read more at straitstimes.com.
Moderna Wins UK Patent Battle Against Pfizer and BioNTech
A U.K. Court of Appeals ruling confirms the validity of a patent covering modifications of mRNA used in Moderna’s vaccines.
Moderna Says U.K. Court Rules in Favor of its EP'949 Patent, Affirms Infringement by Pfizer and BioNTech -- Update
The biotechnology company on Friday said the U.K. Court of Appeal upheld the validity of its EP'949 patent. It noted the decision affirms the court's initial ruling from July 2024 that the patent is valid and infringed by Pfizer/BioNTech's Covid-19 vaccine, Comirnaty.
UK Court of Appeal Confirms Moderna's EP'949 Patent is Valid and Infringed by Pfizer/BioNTech
Moderna, Inc. (NASDAQ:MRNA) today announced that the UK Court of Appeal has upheld the validity of Moderna's EP'949 patent.

Pandemic darlings Moderna, BioNTech are now on two different paths

The Covid-19 pandemic turned Moderna and BioNTech into household names almost overnight. Now the two companies find ...

2BNTX : A Look Ahead: BioNTech's Earnings Forecast

Analysts estimate that BioNTech will report an earnings per share (EPS) of $-1.31. The market awaits BioNTech's announcement, ...

BioNTech initiating another wave of layoffs in Montgomery County

A global biotech is axing more of its Greater Washington workforce, eliminating nearly 100 positions across multiple waves of ...

Bristol Myers Squibb Cuts Full-Year Adjusted View, but Raises Revenue Expectations

Bristol Myers Squibb trimmed its full-year adjusted earnings view as it reported lower second-quarter earnings due to a ...
Morningstar2d

BNTX Stock Price Quote | Morningstar

See the latest BioNTech SE ADR stock price (BNTX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.
USA Today4y

COVID vaccine: How BioNTech used cancer mRNA tech for coronavirus

Türeci co-founded BioNTech, a German company that partnered with pharmaceutical giant Pfizer to develop the first U.S.-authorized COVID-19 vaccine.

BioNTech Q2 2025 Earnings Preview

BioNTech (NASDAQ:BNTX) is scheduled to announce Q2 earnings results on Monday, August 4th, before market open. The consensus EPS Estimate is -$1.65 (+50.9% Y/Y) and the consensus Revenue Estimate is ...
Zacks Investment Research on MSN2d

BioNTech SE Sponsored ADR (BNTX) Is Up 4.81% in One Week: What You Should Know

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell ...